Ninds ward laboratory requires biologicals and reagents in order to continue ongoing experiments and ensure continuity of research in the lab where they are studying inherited neurodegenerative…
Ended Awarded Last action
- Contract number
- 75N95A25F00001
- Awardee
-
New England Biolabs, Inc. UEI EDKJNT8DADG8
- Awarding agency
-
National Institute of Neurological Disorders and Stroke
National Institutes of Health, Department of Health and Human Services
- Obligated
- $17,982
Award facts
- Contract value 100% obligated
- $17,981.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 2 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Ipswich, MA 01938, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $17,982 |
About this award
New England Biolabs, Inc. received a $17,981.60 firm fixed price Blanket Purchase Agreement (BPA) call order from the National Institute of Neurological Disorders and Stroke (NINDS), a component of the National Institutes of Health. This modification to an existing BPA revises terms and conditions while removing IPP instruction language. The contract calls for the delivery of biologicals and reagents to support ongoing research at the NINDS Ward Laboratory, where scientists investigate inherited neurodegenerative diseases. The work is scheduled for completion by May 30, 2025, with performance occurring at New England Biolabs' headquarters in Ipswich, Massachusetts.
This award does not utilize a set-aside designation and is issued under New England Biolabs' existing $10 million single-award BPA with the NIH Office of Logistics and Acquisition Operations, which remains effective through January 31, 2026. New England Biolabs is a leading supplier of molecular biology products, including reagents, enzymes, and sequencing kits, and regularly provides specialized research materials to NIH institutes and other federal agencies supporting biomedical research initiatives. The BPA structure enables NINDS and other NIH components to efficiently procure essential materials needed to maintain continuity of critical research operations.
Description
Ninds ward laboratory requires biologicals and reagents in order to continue ongoing experiments and ensure continuity of research in the lab where they are studying inherited neurodegenerative diseases.
Quick answers
Who was awarded contract 75N95A25F00001?
75N95A25F00001 was awarded to New England Biolabs, Inc. by National Institute of Neurological Disorders and Stroke (National Institutes of Health) on April 9, 2025.
How much is contract 75N95A25F00001 worth?
The government has obligated $17,982 on 75N95A25F00001.
Is contract 75N95A25F00001 an order under another contract?
Yes. 75N95A25F00001 is a BPA call under 75N98024A00061, a blanket purchase agreement.
Was contract 75N95A25F00001 competed?
The extent of competition for 75N95A25F00001 was competed under sap. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award